Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction

Last updated: February 20, 2026
Sponsor: Rodrigo Ruano
Overall Status: Active - Recruiting

Phase

N/A

Condition

Enuresis

Bladder Disorders

Urinary Incontinence

Treatment

Fetoscopes

Fetal Cystoscopy

Clinical Study ID

NCT03281798
20220117-1
16-008556
  • Ages > 18
  • Female

Study Summary

The purpose of the study is to study the outcomes of maternal and fetal patients who are undergoing fetal intervention for severe isolated lower urinary tract obstruction (LUTO).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Pregnant women

  2. Singleton pregnancy

  3. Maternal age ≥ 18 years

  4. Male fetus with LUTO, dilated bladder, "keyhole sign" and bilateral hydronephrosis

  5. Oligohydramnios or Anhydramnios

  6. Favorable urine analysis defined as urinary sodium is < 100 milliequivalents perliter (mEq/L), chloride < 90 mEq/L, and osmolality < 200 milliosmoles per kilogram (mOsm/kg) after 20 weeks and in the absence of previous in utero intervention forthe disease (vesicoamniotic shunt placement or fetal cystoscopy).

  7. Absence of chromosomal abnormalities and associated anomalies

  8. Gestational age at the time of the procedure will be between 16 0/7 weeks and 25 6/7weeks

  9. Normal karyotype by invasive testing (amniocentesis or Chorionic Villus Sampling (CVS)). Patients declining invasive testing will be excluded.

  10. Family have considered and declined the option of termination of the pregnancy atless than 24 weeks.

  11. Family meets psychosocial criteria, including sufficient social support and abilityto understand requirements of the study.

  12. Parents or guardian are willing to provide signed informed consent.

Exclusion

Exclusion Criteria:

  1. Fetal anomaly unrelated to LUTO

  2. Congenital cardiac anomaly

  3. Female fetus

  4. Increased risk for preterm labor including short cervical length (<1.5 cm), historyof incompetent cervix with or without cerclage, and previous preterm birth

  5. Placental abnormalities (previa, abruption, accreta) known at time of enrollment

  6. Contraindications to surgery including previous hysterotomy in active uterinesegment

  7. Technical limitations precluding fetoscopic surgery, such as uterine fibroids, fetalmembrane separation, uterine anomalies incompatible with fetoscopy

  8. Maternal-fetal Rh isoimmunization, Kell sensitization or neonatal alloimmunethrombocytopenia affecting the current pregnancy

  9. Maternal HIV, Hepatitis-B, Hepatitis-C status positive because of the increased riskof transmission to the fetus during maternal-fetal surgery. If the patient's HIV orHepatitis status is unknown, the patient must be tested and found to have negativeresults before enrollment

  10. Maternal medical condition that is a contraindication to surgery or anesthesia

  11. Patient does not have health insurance to cover routine clinical care includingprenatal care, prenatal ultrasound, amniocentesis, tocolysis, admission, delivery,and fetal vesico-amniotic shunting. The exception will be fetal cystoscopy which isconsidered an experimental procedure.

  12. Inability to comply with travel and follow-up requirements of the trial

  13. Participation in another intervention study that influences maternal and fetalmorbidity and mortality or participation in this trial in a previous pregnancy

  14. Patients declining invasive testing

  15. Family does not meet psychosocial criteria including insufficient

Study Design

Total Participants: 10
Treatment Group(s): 2
Primary Treatment: Fetoscopes
Phase:
Study Start date:
January 01, 2018
Estimated Completion Date:
August 01, 2028

Connect with a study center

  • University of Miami

    Miami, Florida 33136
    United States

    Site Not Available

  • University of Miami

    Miami 4164138, Florida 4155751 33136
    United States

    Active - Recruiting

  • Mayo Clinic

    Rochester, Minnesota 55905
    United States

    Site Not Available

  • Mayo Clinic

    Rochester 5043473, Minnesota 5037779 55905
    United States

    Terminated

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.